Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A CitroTech Inc. Filed by: Ralston Theodore

June 3, 2026 5:15 PM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The figures in Rows 7, 9 and 11 include 22,224 shares of Common Stock issuable upon the exercise of warrants to purchase 22,224 shares of Common Stock. (2) The percentage in Row 13 is calculated based on 22,424,083 shares of Common Stock issued and outstanding. This figure is derived from (i) 22,357,412 shares of Common Stock outstanding, as disclosed in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed by the Issuer with the Securities and Exchange Commission on May 15, 2026, (ii) 44,447 shares of Common Stock issued upon the conversion of 13,334 shares of Series C Convertible Preferred Stock held by the Reporting Person, and (iii) 22,224 shares of Common Stock issuable upon exercise of 22,224 warrants.


SCHEDULE 13D


Theodore Ralston
Signature:/s/ Theodore Ralston
Name/Title:Individual
Date:06/03/2026

Categories

SEC Filings